Ludwig Enterprises (LUDG) Loans and Notes Receivables (2024 - 2026)
Ludwig Enterprises posted quarterly Loans and Notes Receivables of $106000.0 for Q4 2025, up 6.0% year-on-year from $100000.0 in Q4 2024, and little changed on a QoQ basis from $106000.0 in Q3 2025.
Ludwig Enterprises (LUDG) has 2 years of Loans and Notes Receivables data on file, last reported at $106000.0 in Q4 2025.
- For the quarter ending Q4 2025, Loans and Notes Receivables rose 6.0% year-over-year to $106000.0; the trailing twelve-month figure through Dec 2025 stood at $106000.0 (up 6.0% YoY), and the FY2025 full-year result was $106000.0, up 6.0% from the prior year.
- Loans and Notes Receivables for Q4 2025 stood at $106000.0, roughly flat from $106000.0 in the prior quarter.
- Across five years, Loans and Notes Receivables topped out at $106000.0 in Q3 2025 and bottomed at $100000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans & Notes Receiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Ludwig Enterprises | - | - | - | 106,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106,000.00 |
| Dec 31, 2025 | 106,000.00 |
| Sep 30, 2025 | 106,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Mar 31, 2025 | 102,000.00 |
| Dec 31, 2024 | 100,000.00 |